TissGeneSummary for ZNF789 |
Gene summary |
Basic gene information | Gene symbol | ZNF789 |
Gene name | zinc finger protein 789 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 7q22.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001013258.1, NM_213603.2, | |
Description | - | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000198556 | ||
HPRD : 14161 | ||
Vega : OTTHUMG00000154601 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ZNF789 | |
BioGPS: 285989 | ||
Pathway | NCI Pathway Interaction Database: ZNF789 | |
KEGG: ZNF789 | ||
REACTOME: ZNF789 | ||
Pathway Commons: ZNF789 | ||
Context | iHOP: ZNF789 | |
ligand binding site mutation search in PubMed: ZNF789 | ||
UCL Cancer Institute: ZNF789 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | StomachTestis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | STADTGCT | |
Reference showing the relevant tissue of ZNF789 | ||
Description by TissGene annotations | Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for ZNF789 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for ZNF789 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for ZNF789 |
TissGeneSNV for ZNF789 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.A166V | UCEC | 2 |
p.I357T | COAD | 1 |
p.H387R | UCEC | 1 |
p.C250Y | UCEC | 1 |
p.I59T | STAD | 1 |
p.R361I | READ | 1 |
p.Q156E | HNSC | 1 |
p.G235A | LUSC | 1 |
p.D56A | PRAD | 1 |
p.E205Q | HNSC | 1 |
p.F2V | HNSC | 1 |
p.A17S | LUAD | 1 |
p.A10S | LUAD | 1 |
p.P101T | KIRC | 1 |
p.R221I | BLCA | 1 |
p.L384I | UCEC | 1 |
p.G309A | LUAD | 1 |
p.K131T | PRAD | 1 |
p.L195F | LUAD | 1 |
p.R221I | COAD | 1 |
p.P75L | STAD | 1 |
p.R386X | COAD | 1 |
p.C250W | HNSC | 1 |
p.R221I | UCEC | 1 |
p.Q360R | SKCM | 1 |
p.Q304H | LUAD | 1 |
p.K8E | ESCA | 1 |
p.R197T | HNSC | 1 |
p.E134* | BLCA | 1 |
p.L188I | PRAD | 1 |
p.C250Y | STAD | 1 |
p.R193Q | READ | 1 |
p.R152K | SKCM | 1 |
p.R386Q | COAD | 1 |
p.T77A | COAD | 1 |
p.Q103H | UCEC | 1 |
p.R277M | UCEC | 1 |
p.R152S | PRAD | 1 |
p.T299A | UCEC | 1 |
p.K264X | COAD | 1 |
p.T377M | PAAD | 1 |
p.P144S | ESCA | 1 |
p.R277M | PRAD | 1 |
p.S90C | LUAD | 1 |
p.V39A | STAD | 1 |
p.R193Q | UCEC | 1 |
p.S379I | READ | 1 |
Top |
TissGeneCNV for ZNF789 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for ZNF789 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | AA664651 | ZNF789-ZNF789 | chr7:99084853 | chr7:99084697 | |
Chimerdb3.0 | ChiTaRs | NA | BG740456 | ZNF789-ZBTB16 | chr7:99080578 | chr11:113937755 | |
Chimerdb3.0 | FusionScan | UCS | TCGA-N5-A4RO-01A | PDAP1-ZNF789 | Out-of-Frame | chr7:98995484 | chr7:99077283 |
Top |
TissGeneNet for ZNF789 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for ZNF789 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for ZNF789 |
TissGeneDrug for ZNF789 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for ZNF789 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |